4D Molecular Therapeutics (FDMT) Climbs 40% Following Positive Data from Phase 2 Trial of Intravitreal 4D-150

Visit StreetInsider.com at http://www.streetinsider.com/Momentum+Movers/4D+Molecular+Therapeutics+%28FDMT%29+Climbs+40%25+Following+Positive+Data+from+Phase+2+Trial+of+Intravitreal+4D-150/22718633.html for the full story.